The evidence with the title 'Enough is enough ' says Address drug costs paid for by both public programs and private insurance  ... And comprise about 40 percent of all drugs currently under development.13  ... .. experts decried these increases ina medical journal.73 . In some instances, these price spikes were the result of a new company buying the rights to the drug . 
